Dog Health Risks by Breed: Cardiac, Orthopedic, Neurological, and Cancer Risks by Breed

Dog Health Risks by Breed: Cardiac, Orthopedic, Neurological, and Cancer Risks by Breed

🐕
Reviewed by a Doctor of Veterinary Medicine (DVM)
Small Animal Internal Medicine and Clinical Genetics
Understanding breed-specific health risks before acquiring a dog, and monitoring for them throughout the dog’s life, is one of the most consequential things an owner can do for their dog’s health outcomes. In clinical practice, the conditions that cause the most suffering and the most preventable deaths are rarely surprises to anyone who knows the breed: the Cavalier King Charles Spaniel with advanced mitral valve disease, the German Shepherd with degenerative myelopathy, the Golden Retriever with hemangiosarcoma, the Dachshund with acute disc herniation causing paralysis. These are not unlucky exceptions – they are well-documented, breed-defining risks with known frequencies. The role of breed-specific health knowledge is not to cause anxiety but to enable appropriate monitoring schedules, informed financial planning (including whether pet insurance is particularly advisable for a given breed), and early detection when screening is available. A dog owner who knows their Labrador Retriever has a meaningful probability of developing hip dysplasia, exercise-induced collapse, and progressive retinal atrophy will seek appropriate screening rather than waiting for clinical signs – and will get substantially better outcomes when conditions are identified early. This article organizes the most clinically significant breed health risks by disease category, the breeds most affected, and what owners can do.

Key Takeaways

  • Breed-specific health risks are organized here by disease system – cardiac, orthopedic, neurological, oncological, respiratory, and metabolic – because understanding which system a breed is predisposed toward determines the monitoring approach. A breed with elevated cardiac risk needs echocardiographic screening; a breed with elevated orthopedic risk needs OFA radiographic evaluation; a breed with elevated cancer mortality needs attentive physical examinations and prompt evaluation of any new masses. Different risk profiles require different preventive actions.
  • The highest-risk breeds for single major conditions include: Cavalier King Charles Spaniel (mitral valve disease – near 100% prevalence by age 10); Dachshund (intervertebral disc disease – chondrodystrophic conformation); Doberman Pinscher (dilated cardiomyopathy – occult DCM can be present for years before symptoms); Golden Retriever (cancer – 60-70% lifetime cancer mortality); German Shepherd Dog (degenerative myelopathy, exocrine pancreatic insufficiency, hip dysplasia); Great Dane (bloat/GDV – highest rate of any breed); Boxer (multiple cancers, cardiomyopathy, brachycephalic airway); and all extreme brachycephalic breeds (BOAS). Owners of these breeds should discuss breed-specific screening schedules with their veterinarian.
  • Many of the most serious breed-specific conditions have DNA tests available that allow prospective owners to screen breeding animals and, increasingly, individual dogs. DNA tests exist for: progressive retinal atrophy (multiple forms), degenerative myelopathy, exercise-induced collapse, hereditary cataracts, Fanconi syndrome, MDR1/ABCB1 drug sensitivity, von Willebrand’s disease, and many others. Reputable breeders perform DNA testing relevant to their breed and provide results to puppy buyers. A negative DNA test result does not eliminate all health risk but substantially reduces the probability of a specific heritable condition.
  • The MDR1/ABCB1 gene mutation deserves special attention because it affects drug metabolism rather than causing a specific disease – but its consequences can be life-threatening. Dogs carrying this mutation (most commonly Australian Shepherds, Collies, Shetland Sheepdogs, Border Collies, and related herding breeds) have increased blood-brain barrier permeability to certain drugs, including ivermectin (at doses used for other species), loperamide (Imodium), some chemotherapy agents, and several other commonly used medications. A dog from an affected breed should be DNA-tested for MDR1/ABCB1 before any drug exposure where this mutation is relevant. Veterinarians managing dogs from these breeds should be informed of the breed and the mutation status.
  • Pet insurance economics vary dramatically by breed because insurers price actuarially – they know the claim frequencies. English Bulldogs, French Bulldogs, and Cavalier King Charles Spaniels consistently have the highest pet insurance premiums and are sometimes subject to breed-specific exclusions for conditions that are statistically near-certain (Cavalier cardiac disease, brachycephalic airway claims). For these breeds, pet insurance is particularly worth evaluating early – ideally before the dog develops any pre-existing conditions that would be excluded – and the financial planning discussion with a veterinarian about likely lifetime care costs is an important part of ownership preparation.

Cardiac Risks by Breed

Condition Highest-Risk Breeds Screening Recommendation
Mitral valve disease (MVD) / myxomatous mitral valve disease Cavalier King Charles Spaniel (near-universal by age 10); also elevated in Dachshund, Miniature and Toy Poodle, Chihuahua, Shih Tzu, Maltese Annual cardiac auscultation; echocardiogram when murmur detected; Cavalier MVD Breeding Protocol for breeders
Dilated cardiomyopathy (DCM) Doberman Pinscher (30-40% affected); Great Dane; Boxer; Irish Wolfhound; Newfoundland; Cocker Spaniel; also elevated in Golden Retriever Annual echocardiogram and Holter monitor for Dobermans from age 3-4; clinical signs often absent until advanced disease
Subaortic stenosis (SAS) Newfoundland; Boxer; Golden Retriever; Rottweiler; German Shepherd Cardiac auscultation at puppy purchase; echocardiogram to grade severity if murmur detected
Arrhythmogenic right ventricular cardiomyopathy (ARVC) Boxer (Boxer cardiomyopathy); English Bulldog Holter monitor and echocardiogram; Boxers may have normal exam with significant arrhythmia on Holter
Patent ductus arteriosus (PDA) Poodle; Bichon Frise; Pomeranian; Yorkshire Terrier; Maltese; Chihuahua; Springer Spaniel Cardiac auscultation at first puppy exam – continuous “machinery” murmur; surgical correction recommended when identified

Orthopedic Risks by Breed

Condition Highest-Risk Breeds What Owners Can Do
Hip dysplasia German Shepherd Dog; Labrador Retriever; Golden Retriever; Rottweiler; Saint Bernard; Mastiff; Bernese Mountain Dog OFA hip certification of breeding animals; radiographic screening of affected breeds; weight management critical to outcome
Elbow dysplasia Labrador Retriever; German Shepherd Dog; Bernese Mountain Dog; Rottweiler; Golden Retriever; Newfoundland OFA elbow certification; radiographic evaluation at age 2+ in affected breeds; front limb lameness in young large breeds warrants evaluation
Intervertebral disc disease (IVDD) Dachshund (highest rate); French Bulldog; Bulldog; Basset Hound; Pembroke Welsh Corgi; Beagle; Cocker Spaniel Weight management; limit high-impact jumping; prompt veterinary evaluation for back pain or hind limb weakness; MRI at onset of neurological signs
Patellar luxation Chihuahua; Toy Poodle; Yorkshire Terrier; Pomeranian; Maltese; Bichon Frise; Boston Terrier Grading on annual exam; surgical correction recommended for Grade 3-4; avoid obesity
Osteochondrosis dissecans (OCD) Labrador Retriever; Golden Retriever; Rottweiler; Great Dane; Bernese Mountain Dog (shoulder, elbow, hock joints) Appropriate growth-rate management in large breed puppies; large-breed puppy diet; avoid calcium supplementation
Legg-Calve-Perthes disease Miniature Pinscher; Yorkshire Terrier; Toy Poodle; West Highland White Terrier; Manchester Terrier (avascular necrosis of femoral head in small breeds) Hind limb lameness in small breed puppies 4-11 months warrants radiographic evaluation; surgical treatment is effective

Neurological Risks by Breed

Condition Highest-Risk Breeds Clinical Notes
Degenerative myelopathy (DM) German Shepherd Dog; Pembroke Welsh Corgi; Boxer; Chesapeake Bay Retriever; Rhodesian Ridgeback; Bernese Mountain Dog DNA test available (SOD1 mutation); progressive hind limb weakness beginning age 8+ that advances to paralysis; no effective treatment; DNA testing before breeding
Epilepsy (idiopathic) Labrador Retriever; Golden Retriever; Border Collie; German Shepherd; Australian Shepherd; Beagle; Belgian Shepherd First seizure after age 6 months and before age 5 years with no identifiable cause suggests idiopathic epilepsy; manageable with lifelong medication
Syringomyelia / Chiari-like malformation Cavalier King Charles Spaniel (very high prevalence); Brussels Griffon; King Charles Spaniel; Yorkshire Terrier MRI screening recommended for breeding animals; causes chronic pain, neck sensitivity, phantom scratching; surgical and medical management options
Wobbler syndrome (cervical spondylomyelopathy) Great Dane; Doberman Pinscher; Weimaraner; Borzoi (large/giant breeds) Progressive ataxia and neck pain; MRI or CT for diagnosis; surgical decompression in appropriate cases
MDR1/ABCB1 drug sensitivity Australian Shepherd; Collie; Shetland Sheepdog; Border Collie; Old English Sheepdog; Long-haired Whippet DNA test available and essential for all dogs from affected breeds before drug exposure; inform all veterinarians of breed and test status

Cancer Risk by Breed

Cancer is the leading cause of death in dogs over age 10, but the rates vary dramatically by breed. The following breeds have exceptionally elevated cancer mortality:

Breed Cancer Risk Profile Most Common Cancer Types
Golden Retriever 60-70% lifetime cancer mortality – exceptionally high; Morris Animal Foundation Golden Retriever Lifetime Study ongoing Hemangiosarcoma; lymphoma; osteosarcoma; mast cell tumors
Boxer Among the highest cancer rates of any breed Mast cell tumors; lymphoma; brain tumors (gliomas); histiocytic sarcoma
Bernese Mountain Dog Cancer is the primary cause of shortened lifespan in this breed; median lifespan 7-8 years Histiocytic sarcoma (exceptionally high rate); mast cell tumors; lymphoma
Rottweiler Elevated cancer mortality compared to most breeds Osteosarcoma; lymphoma; histiocytic sarcoma
Scottish Terrier 18x higher rate of transitional cell carcinoma of the bladder than the general dog population Transitional cell carcinoma (bladder); other cancers elevated
Flat-coated Retriever High cancer mortality; relatively short lifespan for a medium breed Histiocytic sarcoma; osteosarcoma; lymphoma
Monthly Home Cancer Screening
For breeds with elevated cancer risk, establish a monthly home examination routine: run your hands along the entire body, checking for any new lumps, enlarged lymph nodes (located under the jaw, in front of the shoulders, in the armpits, in the groin, and behind the knees), or changes in any existing lumps. Any new mass, any asymmetry in lymph node size, unexplained weight loss, or reduced appetite lasting more than 48 hours warrants prompt veterinary evaluation. Fine needle aspiration of a suspicious mass is a quick, inexpensive, low-risk in-office procedure that can meaningfully guide next steps. Never “watch and wait” a new mass for more than 4 weeks without evaluation.

Respiratory Risks: Brachycephalic Breeds

Brachycephalic obstructive airway syndrome (BOAS) affects all breeds with significantly shortened skulls. The severity varies by individual anatomy and may not be clinically apparent to owners who normalize the breed’s characteristic sounds.

Breed BOAS Prevalence Associated Conditions
English Bulldog Very high; near-universal clinical compromise Stenotic nares, elongated soft palate, hypoplastic trachea, everted laryngeal saccules; dystocia requiring C-section; heat intolerance
French Bulldog High; 65-70% with clinically significant BOAS in studies BOAS; spinal abnormalities (hemivertebrae) causing IVDD; skin fold infections; corneal ulcers from shallow eye sockets
Pug High BOAS; Pug Dog Encephalitis (necrotizing meningoencephalitis – fatal neurological condition); corneal ulcers; hemivertebrae
Boston Terrier Moderate-high BOAS (milder than Bulldog/French Bulldog in many lines); corneal ulcers; patellar luxation; deafness (linked to white pigmentation)
Shih Tzu Moderate BOAS; renal dysplasia; portosystemic shunts; corneal ulcers; patellar luxation
Boxer Moderate; longer muzzle than above breeds reduces severity BOAS less severe; elevated arrhythmia and cancer risk (as above)

Metabolic and Endocrine Risks by Breed

Condition Highest-Risk Breeds Key Signs to Monitor
Hypothyroidism Golden Retriever; Labrador Retriever; Doberman Pinscher; Cocker Spaniel; Airedale Terrier; Boxer Weight gain without increased appetite; lethargy; cold intolerance; bilateral symmetric hair loss; dry coat; managed with daily oral levothyroxine
Addison’s disease (hypoadrenocorticism) Standard Poodle; Portuguese Water Dog; Great Dane; Bearded Collie; Soft-coated Wheaten Terrier; West Highland White Terrier Episodic weakness, vomiting, collapse; often presents as recurrent GI illness (“the great pretender”); electrolyte abnormalities on bloodwork; lifelong hormone replacement
Cushing’s disease (hyperadrenocorticism) Poodle; Dachshund; Boxer; Boston Terrier; Beagle; Yorkshire Terrier Increased thirst and urination; pot-bellied appearance; bilateral symmetric hair loss; skin thinning; recurrent skin infections
Exocrine pancreatic insufficiency (EPI) German Shepherd Dog (very high rate); Rough Collie; Chow Chow Weight loss despite normal or increased appetite; voluminous, pale, fatty stools; managed with pancreatic enzyme supplementation with every meal
Portosystemic shunts Yorkshire Terrier; Maltese; Miniature Schnauzer; Poodle; Bichon Frise; Shih Tzu Poor growth in puppies; neurological signs after eating; seizures; surgical correction is definitive treatment

Common Myths About Dog Breed Health Risks

Myth

Health testing by breeders means puppies will not develop heritable conditions.

Fact

Health testing significantly reduces – but does not eliminate – the probability of heritable conditions. OFA hip certification of parents reduces the frequency of hip dysplasia in offspring but does not guarantee individual puppies will have normal hips. DNA tests for conditions with known mutations (degenerative myelopathy, progressive retinal atrophy, EIC) are more definitive – a clear/clear puppy from two tested parents will not develop that specific form of the condition. However, many conditions have complex polygenic inheritance, environmental components, or multiple genetic forms, and testing addresses only the known mutations. Health testing is a meaningful risk reduction tool, not a guarantee.

Myth

If a dog has shown no signs of a heritable condition by middle age, it is safe to assume it will not develop one.

Fact

Many serious breed-specific conditions are late-onset. Doberman DCM typically appears at age 4-8 and can progress silently for years before causing heart failure. Degenerative myelopathy typically begins at age 8 or later. Cavalier MVD is nearly universal by age 10 but may not cause clinical signs until the disease is advanced. Cancer incidence increases significantly after age 7 in most breeds. A middle-aged dog with no current signs is not cleared of breed risk – it is in the period where screening is most valuable, because early detection of progressive conditions provides the longest treatment window.

Myth

Higher purchase price from a breeder means fewer health problems.

Fact

Purchase price correlates poorly with health outcomes. The correlation that matters is between health testing documentation and health outcomes. A $3,000 Labrador Retriever from a breeder who performs OFA hip/elbow certification, EIC DNA testing, and CAER eye exams and shares the results will have meaningfully lower heritable disease rates than a $3,000 Labrador from a breeder who does not perform this testing – regardless of how the prices compare. Before purchasing a puppy, ask for OFA registration numbers (publicly verifiable at ofa.org), not verbal assurances. Price reflects demand, rarity, and marketing, not health testing rigor.

Frequently Asked Questions

What dog breeds have the highest health risks?

By disease category: Cavalier King Charles Spaniel (cardiac – MVD near-universal by age 10); Doberman Pinscher (dilated cardiomyopathy); Dachshund and French Bulldog (IVDD); German Shepherd Dog (degenerative myelopathy, hip dysplasia, EPI); Golden Retriever and Boxer (cancer); Great Dane (bloat/GDV); all extreme brachycephalic breeds – Bulldog, French Bulldog, Pug (BOAS). These breeds have elevated but manageable risks with appropriate monitoring.

How do I find out the health risks for my dog’s breed?

The parent breed club for any AKC-recognized breed publishes health information and recommended health testing. OFA.org maintains breed health statistics and a searchable database of tested dogs. The Canine Health Information Center (CHIC) lists breed-specific required and recommended health tests for participating breeds. Your veterinarian can advise on the specific screening schedule appropriate for your breed.

What is the MDR1 mutation and does my dog need to be tested?

The MDR1/ABCB1 mutation causes increased permeability of the blood-brain barrier to certain drugs, which can be toxic at doses safe for other dogs. It is most common in herding breeds: Australian Shepherd, Collie, Shetland Sheepdog, Border Collie, Old English Sheepdog, and related breeds. Affected dogs can have severe neurological reactions to ivermectin (in livestock doses), loperamide (Imodium), some chemotherapy agents, and other drugs. Any dog from an affected breed should be tested before drug exposures where the mutation is relevant. DNA testing is available through several veterinary diagnostic labs.

Should I get pet insurance for a high-risk breed?

Pet insurance is particularly advisable for breeds with high heritable condition rates and high treatment costs: French Bulldogs and English Bulldogs (BOAS surgery, IVDD, dermatology), Cavalier King Charles Spaniels (cardiac and neurological care), German Shepherds (orthopedic care, DM management), and Golden Retrievers (oncology). Enroll before any conditions develop – pre-existing conditions are excluded from coverage. Compare policies carefully for breed-specific exclusions, which some insurers apply to conditions that are statistically near-certain in specific breeds.

What health tests should I ask a breeder for?

Research the specific tests recommended for your intended breed through the breed’s parent club or CHIC (caninehealthinfo.org). Common tests across many breeds include: OFA hip and elbow radiographic certification, OFA cardiac evaluation, CAER eye exam, and breed-specific DNA tests (degenerative myelopathy, PRA, EIC, MDR1, von Willebrand’s disease, etc.). Ask for OFA registration numbers – they are publicly verifiable at ofa.org. A reputable breeder will have completed the relevant testing and will provide documentation without hesitation.

Can I reduce health risks in a high-risk breed with good care?

Yes, significantly for many conditions. Weight management is the most impactful intervention for orthopedic disease – reducing mechanical joint stress and systemic inflammation. BOAS surgical correction in brachycephalic breeds substantially improves airway function and quality of life. Early cardiac medication in Cavalier King Charles Spaniels with diagnosed MVD is now evidence-supported to delay progression. Annual wellness screening catches progressive conditions at their most treatable stages. Good daily care does not eliminate breed-level genetic risk but materially affects how conditions progress and what treatment options remain available.

What are the signs of bloat in dogs?

Gastric dilatation-volvulus (GDV, or bloat) is a life-threatening emergency most common in large, deep-chested breeds (Great Dane, German Shepherd, Standard Poodle, Weimaraner, Doberman, Boxer). Signs include: unproductive retching or attempts to vomit without producing anything; rapidly distending abdomen; restlessness and inability to get comfortable; excessive drooling; and pale gums. GDV progresses to cardiovascular shock and death within hours if untreated – any dog showing these signs needs emergency veterinary care immediately, not observation. Prophylactic gastropexy at time of spay/neuter is recommended for highest-risk breeds.

For more on managing and preventing health conditions in your dog, explore our complete Dog Health library.

Explore Dog Health Articles

Related Articles

Related Guides
What Kind of Dog Is Scooby-Doo: Great Dane Breed Profile, Health Risks, and Real Temperament